Fig. 2: Biomaterials for immunomodulation through macrophage polarization.
From: Immunomodulatory biomaterials for treating chronic inflammation at mucosal sites
Mannosylated albumin nanoparticles can be utilized to preferentially target CD206+ macrophages to reduce pro-fibrotic cytokine activity and thereby reverse pathologic myofibroblast deposition and ECM remodeling41.
